OMRNF(OMRNF)
OMRNF
No analyst ratings available
No analyst price targets available for OMRNF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $859.88B | $917.19B | $956.45B | $962.65B | $1.00T |
| Low | $859.88B | $917.19B | $956.45B | $962.65B | $1.00T |
| High | $892.21B | $963.14B | $998.60B | $1.01T | $1.05T |
| EBITDA Avg | $104.56B | $111.52B | $116.30B | $117.05B | $121.88B |
| Low | $104.56B | $111.52B | $116.30B | $117.05B | $121.88B |
| High | $108.49B | $117.11B | $121.42B | $122.21B | $127.25B |
| EBIT Avg | $72.85B | $77.71B | $81.03B | $81.56B | $84.92B |
| Low | $72.85B | $77.71B | $81.03B | $81.56B | $84.92B |
| High | $75.59B | $81.60B | $84.60B | $85.15B | $88.67B |
| Net Income Avg | $39.38B | $60.05B | $66.29B | $57.99B | $66.83B |
| Low | $39.38B | $60.05B | $66.29B | $57.99B | $66.83B |
| High | $41.63B | $63.49B | $70.08B | $61.31B | $70.66B |
| EPS Avg | $200.14 | $305.22 | $336.92 | $294.75 | $339.71 |
| Low | $200.14 | $305.22 | $336.92 | $294.75 | $339.71 |
| High | $211.61 | $322.70 | $356.23 | $311.64 | $359.17 |
| Analysts (Rev / EPS) | 10 / 1 | 11 / 1 | 6 / 1 | 7 / 1 | 7 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $201.88B | $211.74B | $247.10B |
| Low | $201.88B | $211.74B | $247.10B |
| High | $201.88B | $211.74B | $247.10B |
| EBITDA Avg | $24.55B | $25.75B | $30.05B |
| Low | $24.55B | $25.75B | $30.05B |
| High | $24.55B | $25.75B | $30.05B |
| EBIT Avg | $17.10B | $17.94B | $20.93B |
| Low | $17.10B | $17.94B | $20.93B |
| High | $17.10B | $17.94B | $20.93B |
| Net Income Avg | $6.83B | $9.82B | $18.78B |
| Low | $6.83B | $9.82B | $18.78B |
| High | $6.83B | $9.82B | $18.78B |
| EPS Avg | $34.71 | $49.92 | $95.47 |
| Low | $34.71 | $49.92 | $95.47 |
| High | $34.71 | $49.92 | $95.47 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |